Monopoly Rights for Cyproheptadine Tricholine Syrup

Name: Cyproheptadine + Tricholine Citrate Syrup PCD Franchise
Brand: Cyproslab T Syrup
Rating: 4.8 (150 reviews)

High Turnover: Guaranteed Sales Volume

Cyproslab T Edge: Top Doctor-Prescribed Appetizer

Secure Exclusive Territory in General/Pediatric Segment

Low Investment, Full Marketing Material Support

Launch Your High-Margin Syrup Business Today

Home/Products /cyproheptadine-hcl-i-p-2-mg-tricholine-citrate-i-p-275-mg-syrup

Therapeutic

ENDOCRINOLOGY and Hormonal range

Gastroenterology

General and OTC medicines

Gynecology and Fertility

Hepatology

Hypertension/ Blood Pressure

Nutraceuticals, Multivitamins and Multiminerals

Sedative or Antianxiety

Monopoly rights Cyproslab T Syrup across Punjab

Pediatric pharma franchise opportunity in Kolkata

Top PCD business for syrups in Bhubaneswar

Cyproheptadine Tricholine Citrate PCD Franchise Literature PDF

Cyproslab T Syrup

Composition : Cyproheptadine HCl I.P. 2 mg + Tricholine Citrate I.P. 275 mg Syrup

Dosage Form : Syrup

Packaging Type : Bottle

Packaging : 100ml

Price : ₹135/-

Contact For Business Query

Cyproslab T Syrup (Cyproheptadine 2mg + Tricholine Citrate 275mg) is a high-turnover, high-profit product built for our PCD Pharma Franchise partners.

This established combination is essential for improving appetite, promoting weight gain, and supporting liver function (Tricholine Citrate). This guarantees strong, persistent demand across both the pediatric and general physician segments.

Why Cyproslab T is Your Key to Profit:

High Volume, Consistent Demand: As a widely prescribed appetite stimulant and liver tonic, this product ensures rapid restocking cycles and consistently high sales volume throughout the year.
Excellent Profit Margins: Positioned in a high-demand therapeutic segment, the product allows for competitive pricing while securing superior profit margins on every unit sold.
Doctor Loyalty: The established, reliable composition builds immediate prescription trust from pediatricians and general practitioners, securing your long-term repeat orders.
Monopoly Opportunity: We offer exclusive rights for your area—meaning zero competition in your designated territory. Partner with us for full marketing support and timely supply to turn this essential, fast-moving product into guaranteed business growth.

Contact us today to secure this high-turnover syrup segment!

About the Product

Cyproslab T Syrup (Cyproheptadine 2mg + Tricholine Citrate 275mg) is a high-turnover, high-profit product built for our PCD Pharma Franchise partners.

Why Cyproslab T is Your Key to Profit:

High Volume, Consistent Demand: As a widely prescribed appetite stimulant and liver tonic, this product ensures rapid restocking cycles and consistently high sales volume throughout the year.
Excellent Profit Margins: Positioned in a high-demand therapeutic segment, the product allows for competitive pricing while securing superior profit margins on every unit sold.
Doctor Loyalty: The established, reliable composition builds immediate prescription trust from pediatricians and general practitioners, securing your long-term repeat orders.
Monopoly Opportunity: We offer exclusive rights for your area—meaning zero competition in your designated territory. Partner with us for full marketing support and timely supply to turn this essential, fast-moving product into guaranteed business growth.

Contact us today to secure this high-turnover syrup segment!

Patients may experience injection site discomfort, gastrointestinal upset (nausea, vomiting, diarrhea), rash, or mild liver enzyme elevations. Less commonly, hypersensitivity reactions and hematologic abnormalities such as eosinophilia or neutropenia may occur. Rare instances of C. difficile-associated diarrhea should be considered during prolonged use.

This formulation is used in the treatment of severe systemic infections such as urinary tract infections, lower respiratory tract infections (including pneumonia), intra-abdominal infections, skin and soft tissue infections, gynecological infections, and septicemia caused by susceptible gram-negative bacteria. It is particularly valuable in hospital-acquired infections or polymicrobial infections when used in combination with other antimicrobials.

This injection should only be used under the supervision of a qualified healthcare professional. Renal function should be monitored in long-term or high-dose treatments, and dose adjustment may be required in renal impairment. Aztreonam is not effective against gram-positive or anaerobic organisms, and should be used in combination therapy if mixed infections are suspected.

Store in a cool, dry place below 25°C, protected from direct sunlight. Keep the bottle tightly closed and out of reach of children.